[1]丁 宁,谷晓珂,张 伟,等.氢吗啡酮在房颤心脏射频消融术中的应用[J].郑州大学学报(医学版),2018,(03):337-340.[doi:10.13705/j.issn.1671-6825.2017.11.019]
 DING Ning,GU Xiaoke,ZHANG Wei,et al.Application of hydromorphone in radiofrequency ablation of atrial fibrillation[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2018,(03):337-340.[doi:10.13705/j.issn.1671-6825.2017.11.019]
点击复制

氢吗啡酮在房颤心脏射频消融术中的应用()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2018年03期
页码:
337-340
栏目:
应用研究
出版日期:
2018-03-20

文章信息/Info

Title:
Application of hydromorphone in radiofrequency ablation of atrial fibrillation
作者:
丁 宁谷晓珂张 伟韩雪萍
郑州大学第一附属医院麻醉科 郑州 450052
Author(s):
DING NingGU XiaokeZHANG WeiHAN Xueping
Department of Anesthesiology,the First Affiliated Hospital, Zhengzhou University,Zhengzhou 450052
关键词:
房颤 心脏射频消融术 氢吗啡酮
Keywords:
atrial fibrillation cardiac radiofrequency ablation hydromorphone
分类号:
R654.27
DOI:
10.13705/j.issn.1671-6825.2017.11.019
摘要:
目的:探讨氢吗啡酮用于房颤心脏射频消融术的效果。方法:选择行心脏射频消融术的房颤患者60例,分为芬太尼组(30例)和氢吗啡酮组(30例)。在房间隔穿刺成功后,芬太尼组给予芬太尼1 μg/kg静脉注射,随后以1 μg/(kg·h)持续泵注维持; 氢吗啡酮组给予氢吗啡酮1 mg静脉注射。比较两组患者入手术室(T0)、手术开始(T1)、射频消融(T2)、手术结束(T3)时的血压和血氧饱和度(SpO2),消融时VAS评分和Ramsay评分,以及术后麻醉相关不良反应发生情况。结果:两组患者T1、T2、T3时平均动脉压(MAP)均较T0时升高,T2时SpO2降低(P<0.05); 氢吗啡酮组MAP较芬太尼组降低(P<0.05)。与芬太尼组比较,氢吗啡酮组消融时VAS评分较低,Ramsay评分较高(P<0.05),补救药物使用率较低,麻醉满意率较高(P<0.05)。两组患者呼吸抑制、头晕、恶心、呕吐、口干、便秘的发生率差异无统计学意义(P>0.05)。结论:氢吗啡酮可以有效缓解房颤患者心脏射频消融术中的疼痛,安全性良好。
Abstract:
Aim: To observe the analgesic effect and safety of hydromorphone in patients with atrial fibrillation during radiofrequency ablation.Methods: A total of 60 patients with atrial fibrillation undergoing cardiac radiofrequency ablation were divided into fentanyl group(30 cases)and hydromorphone group(30 cases). After atrial septal puncture, fentanyl group received intravenous injection of 1 μg/kg fentanyl, followed by 1 μg/(kg·h)continuous infusion to maintain, hydromorphone group was given intravenous injection of 1 mg hydromorphone. The blood pressure and SpO2 between the two groups when entering the operation room(T0), at the beginning of the operation(T1), radiofrequency ablation(T2), at the end of operation(T3), were compared.VAS and Ramsay score at radiofrequency ablation and the occurrence of postoperative anesthesia complications were recorded.Results: Compared with T0, MAP significantly increased at T1, T2 and T3 in the two groups.MAP of hydromorphone group was lower than that of fentanyl group(P<0.05). SpO2 at T2 was lower than the other time points in the two groups(P<0.05). Compared with those of fentanyl group, VAS score was significantly lower and Ramsay score was higher in hydromorphone group at radiofrequency ablation(P<0.05), rescue medication use rate was lower, and the satisfaction to anesthesia was higher(P<0.05). The incidences of respiratory depression, dizziness, nausea, vomiting, dry mouth, or constipation between the two groups had no statistical differences(P>0.05).Conclusion: Hydromorphone could effectively relieve the pain of patients undergoing radiofrequency ablation, and is safe.

参考文献/References:

[1] 张麒,姚星星,刘鸿昊,等.射频消融术后晚期心房颤动复发危险因素的研究进展[J].中国胸心血管外科临床杂志,2017(8):649
[2] JANUARY CT,WANN LS,ALPERT JS,et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the heart rhythm society[J].Circulation,2014,64(21):e1
[3] SHI LZ,HENG R,LIU SM,et al.Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: a meta-analysis of randomized controlled trials[J].Exp Ther Med,2015,10(2):816
[4] KIRCHHOF P,BENUSSI S,KOTECHA D,et al.2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J].Eur Heart J,2016,37(38):2893
[5] KUMAR P,SUNKARANENI S,SIROHI S,et al.Hydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation[J].Eur J Pharmacol,2008,597(1/3):39
[6] GEORGES P,LAVAND'HOMME P.Intrathecal hydromorphone instead of the old intrathecal morphine:the best is the enemy of the good?[J].Eur J Anaesthesiol, 2012,29(1):3
[7] FELDEN L,WALTER C,HARDER S,et al.Comparative clinical effects of hydromorphone and morphine: a meta-analysis[J].Br J Anaesth,2011,107(3):319
[8] 吴新民,罗爱伦,田玉科,等.术后恶心呕吐防治专家意见(2012)[J].临床麻醉学杂志,2012,28(4):413
[9] 艾克拜尔·安尼瓦尔,李俊红,木拉提·阿不都热合曼.心房颤动治疗的研究新进展[J].中国循环杂志,2014(11):955
[10]OOSTEN AW,OLDENMENGER WH,MATHIJSSEN RH,et al.A systematic review of prospective studies reporting adverse events of commonly used opioids for cancer-related pain: a call for the use of standardized outcome measures[J]. J Pain,2015,16(10):935
[11]刘汝,胡啸玲,易汉,等.盐酸氢吗啡酮的临床研究进展[J].中国处方药,2014(3):119
[12]欧阳映晖.术前应用盐酸氢吗啡酮防止腹腔镜胆囊切除术苏醒期躁动的效果[J].中华临床医师杂志:电子版,2015,9(1):72
[13]Shin SH,Lee HS,KIM SK,et al.Clinical usefulness of hydromorphone-OROS in improving sleep disturbances in Korean cancer patients: a multicenter, prospective, open-label study[J].Cancer Res Treat,2014,46(4):331

备注/Memo

备注/Memo:
【基金项目】河南省教育厅科技攻关项目(18B610008)
【作者简介】张伟,通信作者,女,1970年5月生,博士,主任医师,研究方向:麻醉学,E-mail:15238092177@163.com
更新日期/Last Update: 2018-05-20